Trump to announce pharma tariffs soon

U.S. President Donald Trump said on Friday that he would soon announce tariffs targeting the pharmaceutical industry but did not provide details on timing or rates.

Speaking to reporters aboard Air Force One, Trump also stated that he was open to negotiating deals with countries seeking to avoid U.S. tariffs, but such agreements would have to come after his administration announces reciprocal tariffs on April 2.

Countries including Britain have approached the U.S. to discuss potential deals, Trump said.

“They want to make deals. It’s possible if we can get something for the deal,” he noted. However, when asked if these deals could happen before April 2, he ruled it out, saying, “No, probably later. It’s a process.”

Earlier, President Trump announced a 25% tariff on auto imports, claiming it would boost domestic manufacturing. The White House expects the move to generate $100 billion annually, but it could strain automakers reliant on global supply chains.

The tariffs, set to take effect in April, may raise costs and lower sales, though Trump insists they will lead to more U.S. factories.

Declaring the decision “permanent,” he also warned the EU and Canada of even higher tariffs if they coordinate against the U.S.

Related Posts

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

New Delhi: In a major crackdown on the sale of expired and substandard products, the Central Range team of Delhi Police Crime Branch has arrested one person and seized nearly…

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

Washington:  On March 18, 2026, the U.S. Food and Drug Administration (FDA) issued a draft guidance titled General Considerations for the Use of New Approach Methodologies in Drug Development. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

US market to dent India pharma earnings even as domestic growth remains firm

US market to dent India pharma earnings even as domestic growth remains firm

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg